Skip Navigation LinksHome > Information for Authors

Information for Authors

JAIDS Journal of Acquired Immune Deficiency Syndromes
  accepts manuscript submissions through a submission service on another website. 

JAIDS Journal of Acquired Immune Deficiency Syndromes
has specific instructions and guidelines for submitting articles. Those instructions and guidelines are readily available on the submission service site. Please read and review them carefully. Articles that are not submitted in accordance with our instructions and guidelines are more likely to be rejected.

Manuscript Submission

Clicking on the submission service links on this page will open our manuscript submission service website in a new browser window. Please check section descriptions below to ensure submission to the right section. 

Submit a manuscript - Basic and Translational Science

The Basic and Translational Science section of JAIDS handles manuscripts involving the molecular biology of HIV, the immune response to HIV infection, potential targets for prevention and/or therapeutic strategies, and work that integrates advancements in these areas with clinical trials.

Submit a manuscript - Clinical Science

The Clinical Science section of JAIDS accepts original manuscripts that present new research findings on the clinical presentation, prognosis, treatment and outcomes of HIV infection and associated conditions, preferring prospective cohort studies or hypotheses testing studies with case – control or randomized intervention design rather than cross-sectional single – cohort descriptions.  Manuscripts summarizing the effects of new systems of clinical management, particularly in resource-limited settings are sought and reviewed in conjunction with the JAIDS Implementation and Operational Research Working Group.

Submit a manuscript - Epidemiology and Prevention

The Epidemiology and Prevention section of JAIDS solicits original manuscripts that apply population and cohort data to understand HIV pathogenesis and natural history; that describe the rates and risk factors for HIV infection in diverse populations; that guide understanding of optimal treatment, care, prevention and intervention approaches to the clinical practice and public health scale up and that address objectives of evidence for preventative intervention in clinical and population-based trials.


  ***New Focus Area: Hepatitis B virus (HBV) and hepatitis C virus (HCV)***

JAIDS is now accepting manuscripts for a new focus area of interest: HBV and HCV  
The investment in HIV research has allowed us to make huge advances in controlling a formerly brutal epidemic. Now, what we've learned from HIV is being applied to hepatitis viruses, both HBV and especially HCV where curative treatments are on the verge of transforming that epidemic as well. JAIDS believes there is a clear synergy in these research efforts and that on all levels these research efforts are vital to share across the boundaries of interest of specific viral infections. JAIDS looks forward to publishing the best of this work and calls for manuscripts in HCV and HBV research as well as in ongoing work against HIV infection.

View the latest Instructions to Authors.